Yiran Gan 4/4/25 Yiran Gan 4/4/25 Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Potential applications of magnetic particles to detect and treat Alzheimer's disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 A sensitive platform for in vitro immunoassay based on biofunctionalized magnetic nanoparticles and magneto-optical Faraday effect Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Development of a real time imaging-based guidance system of magnetic nanoparticles for targeted drug delivery Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 New perspectives in the search for reliable biomarkers in Alzheimer disease Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts Read More Yiran Gan 4/4/25 Yiran Gan 4/4/25 A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP Read More Newer Posts Older Posts
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Potential applications of magnetic particles to detect and treat Alzheimer's disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 A sensitive platform for in vitro immunoassay based on biofunctionalized magnetic nanoparticles and magneto-optical Faraday effect Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Analytical performance of reagent for assaying tau protein in human plasma and feasibility study screening neurodegenerative diseases Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Development of a real time imaging-based guidance system of magnetic nanoparticles for targeted drug delivery Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 New perspectives in the search for reliable biomarkers in Alzheimer disease Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer’s Dementia: Findings in Two Cohorts Read More
Yiran Gan 4/4/25 Yiran Gan 4/4/25 A synthetic cationic antimicrobial peptide inhibits inflammatory response and the NLRP3 inflammasome by neutralizing LPS and ATP Read More
